It was also shown that ACAT1/SOAT1 inhibition cleared cholesterol ester lipid droplets in microglia bearing mutant TREM2 [62], and in human IPSC-derived neurons from AD patients [63]. This evidence concerns the gene ACAT1 and Alzheimer disease.